心房颤动的抗栓治疗 - Suppr

Suppr

超能文献

Antithrombotic therapy in atrial fibrillation.

作者信息

Laupacis A, Albers G, Dalen J, Dunn M I, Jacobson A K, Singer D E

机构信息

Clinical Epidemiology Unit, Ottawa Hospital, Civic Campus, ON, Canada.

出版信息

Chest. 1998 Nov;114(5 Suppl):579S-589S. doi: 10.1378/chest.114.5_supplement.579s.

DOI:10.1378/chest.114.5_supplement.579s

PMID:9822064

Abstract

摘要

相似文献

Antithrombotic therapy in atrial fibrillation.

Chest. 1998 Nov;114(5 Suppl):579S-589S. doi: 10.1378/chest.114.5_supplement.579s.

Nonrheumatic atrial fibrillation. Risk of stroke and role of antithrombotic therapy.

Circulation. 1991 Aug;84(2):469-81. doi: 10.1161/01.cir.84.2.469.

Warfarin versus aspirin in the elderly in primary prophylaxis for atrial fibrillation.

Age Ageing. 2007 Mar;36(2):117-9. doi: 10.1093/ageing/afl181. Epub 2007 Jan 25.

Antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls.

J Fam Pract. 1999 Jul;48(7):498.

Warfarin vs aspirin and AFASAK 2.

Arch Intern Med. 1999 May 10;159(9):1010-1. doi: 10.1001/archinte.159.9.1010.

Atrial fibrillation and anticoagulation.

Adv Intern Med. 1999;44:239-65.

Anticoagulant therapy for atrial fibrillation. Recommendations from major studies.

Postgrad Med. 1992 Sep 1;92(3):119-24, 129-30. doi: 10.1080/00325481.1992.11701444.

Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals.

Arch Intern Med. 1996 Nov 11;156(20):2311-6.

ABC of atrial fibrillation. Antithrombotic treatment for atrial fibrillation.

BMJ. 1996 Jan 6;312(7022):45-9. doi: 10.1136/bmj.312.7022.45.

Atrial fibrillation: the epidemic of the new millennium.

Ann Intern Med. 1999 Oct 5;131(7):537-8. doi: 10.7326/0003-4819-131-7-199910050-00011.

引用本文的文献

Cardiovascular and renal protective effects of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation.

PLoS One. 2022 Oct 13;17(10):e0275103. doi: 10.1371/journal.pone.0275103. eCollection 2022.

Atrial Fibrillation: The New Epidemic of the Ageing World.

J Atr Fibrillation. 2009 Apr 1;1(6):154. doi: 10.4022/jafib.154. eCollection 2009 Apr-May.

Dental management of patients taking novel oral anticoagulants (NOAs): Dabigatran.

J Clin Exp Dent. 2017 Feb 1;9(2):e289-e293. doi: 10.4317/jced.53219. eCollection 2017 Feb.

Atrial fibrillation: review of current treatment strategies.

J Thorac Dis. 2016 Sep;8(9):E886-E900. doi: 10.21037/jtd.2016.09.13.

Trends in antithrombotic therapy for atrial fibrillation: Data from the Veterans Health Administration Health System.

Am Heart J. 2016 Sep;179:186-91. doi: 10.1016/j.ahj.2016.03.029. Epub 2016 Jun 21.

Anticoagulation Management in Patients with Pacemaker-Detected Atrial Fibrillation.

Open Access Maced J Med Sci. 2016 Jun 15;4(2):243-7. doi: 10.3889/oamjms.2016.053. Epub 2016 Apr 20.

The risk stratification in atrial fibrillation.

Intern Emerg Med. 2012 Oct;7 Suppl 3:S233-40. doi: 10.1007/s11739-012-0805-x.

Atrial fibrillation (chronic).

BMJ Clin Evid. 2011 Nov 10;2011:0217.

Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial.

BMJ. 2011 Jun 23;342:d3653. doi: 10.1136/bmj.d3653.

Prevention of cardioembolic stroke.

Neurotherapeutics. 2011 Jul;8(3):488-502. doi: 10.1007/s13311-011-0048-y.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Antithrombotic therapy in atrial fibrillation.

Chest. 1998 Nov;114(5 Suppl):579S-589S. doi: 10.1378/chest.114.5_supplement.579s.

Nonrheumatic atrial fibrillation. Risk of stroke and role of antithrombotic therapy.

Circulation. 1991 Aug;84(2):469-81. doi: 10.1161/01.cir.84.2.469.

Warfarin versus aspirin in the elderly in primary prophylaxis for atrial fibrillation.

Age Ageing. 2007 Mar;36(2):117-9. doi: 10.1093/ageing/afl181. Epub 2007 Jan 25.

Antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls.

J Fam Pract. 1999 Jul;48(7):498.

Warfarin vs aspirin and AFASAK 2.

Arch Intern Med. 1999 May 10;159(9):1010-1. doi: 10.1001/archinte.159.9.1010.

Atrial fibrillation and anticoagulation.

Adv Intern Med. 1999;44:239-65.

Anticoagulant therapy for atrial fibrillation. Recommendations from major studies.

Postgrad Med. 1992 Sep 1;92(3):119-24, 129-30. doi: 10.1080/00325481.1992.11701444.

Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals.

Arch Intern Med. 1996 Nov 11;156(20):2311-6.

ABC of atrial fibrillation. Antithrombotic treatment for atrial fibrillation.

BMJ. 1996 Jan 6;312(7022):45-9. doi: 10.1136/bmj.312.7022.45.

Atrial fibrillation: the epidemic of the new millennium.

Ann Intern Med. 1999 Oct 5;131(7):537-8. doi: 10.7326/0003-4819-131-7-199910050-00011.

引用本文的文献

Cardiovascular and renal protective effects of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation.

PLoS One. 2022 Oct 13;17(10):e0275103. doi: 10.1371/journal.pone.0275103. eCollection 2022.

Atrial Fibrillation: The New Epidemic of the Ageing World.

J Atr Fibrillation. 2009 Apr 1;1(6):154. doi: 10.4022/jafib.154. eCollection 2009 Apr-May.

Dental management of patients taking novel oral anticoagulants (NOAs): Dabigatran.

J Clin Exp Dent. 2017 Feb 1;9(2):e289-e293. doi: 10.4317/jced.53219. eCollection 2017 Feb.

Atrial fibrillation: review of current treatment strategies.

J Thorac Dis. 2016 Sep;8(9):E886-E900. doi: 10.21037/jtd.2016.09.13.

Trends in antithrombotic therapy for atrial fibrillation: Data from the Veterans Health Administration Health System.

Am Heart J. 2016 Sep;179:186-91. doi: 10.1016/j.ahj.2016.03.029. Epub 2016 Jun 21.

Anticoagulation Management in Patients with Pacemaker-Detected Atrial Fibrillation.

Open Access Maced J Med Sci. 2016 Jun 15;4(2):243-7. doi: 10.3889/oamjms.2016.053. Epub 2016 Apr 20.

The risk stratification in atrial fibrillation.

Intern Emerg Med. 2012 Oct;7 Suppl 3:S233-40. doi: 10.1007/s11739-012-0805-x.

Atrial fibrillation (chronic).

BMJ Clin Evid. 2011 Nov 10;2011:0217.

Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial.

BMJ. 2011 Jun 23;342:d3653. doi: 10.1136/bmj.d3653.

Prevention of cardioembolic stroke.

Neurotherapeutics. 2011 Jul;8(3):488-502. doi: 10.1007/s13311-011-0048-y.